A detailed history of Janus Henderson Group PLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 10,541,528 shares of APLT stock, worth $102 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
10,541,528
Previous 7,648,205 37.83%
Holding current value
$102 Million
Previous $35.7 Million 150.87%
% of portfolio
0.05%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.35 - $8.5 $12.6 Million - $24.6 Million
2,893,323 Added 37.83%
10,541,528 $89.6 Million
Q2 2024

Aug 14, 2024

BUY
$4.04 - $6.37 $4.98 Million - $7.86 Million
1,233,563 Added 19.23%
7,648,205 $35.7 Million
Q1 2024

May 15, 2024

BUY
$2.25 - $7.4 $9.6 Million - $31.6 Million
4,266,179 Added 198.57%
6,414,642 $43.6 Million
Q4 2023

Feb 14, 2024

BUY
$1.84 - $3.35 $3.95 Million - $7.2 Million
2,148,463 New
2,148,463 $7.2 Million

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $462M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.